Comparable stake leader
GENERAL ATLANTIC, L.P.
SEC ownership of Pharvaris N.V.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001830487.
Disclosed value leader
FMR LLC
Comparable rows
50/50
Latest evidence
14 Aug 2026
- Public ticker
- PHVS on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
GENERAL ATLANTIC, L.P.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
GENERAL ATLANTIC, L.P.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
14 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001830487
- Issuer location
- Leiden
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Pharvaris N.V. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GENERAL ATLANTIC, L.P.
Disclosed value leader
FMR LLC
Comparable rows
50/50
Latest evidence
14 Aug 2026
13F
13D/G
3/4/5
Lead comparable stake: 7.6%
13D/G row: GENERAL ATLANTIC, L.P.
Showing 1-8 of 50 holder rows.
Quick read
GENERAL ATLANTIC, L.P. leads the comparable SEC ownership view at 7.6%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GENERAL ATLANTIC, L.P.'s linked filing trail.
Comparable ownership
Top 5
GENERAL ATLANTIC, L.P.
7.6%
VIKING GLOBAL INVESTORS LP
5.6%
V Cooperatieve U.a. Lsp
4.9%
Venrock Healthcare Capital Partne...
3.8%
Bain Capital Life Sciences Fund, ...
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GENERAL ATLANTIC, L.P. |
13F
13D/G
Company
|
7.6%
from 13D/G
|
$226,525,177
6,550,757 shares
|
— | 30 Jun 2026 |
| VIKING GLOBAL INVESTORS LP |
13F
13D/G
Company
|
5.6%
from 13D/G
|
$126,331,460
3,653,310 shares
|
— | 30 Jun 2026 |
| V Cooperatieve U.a. Lsp |
13D/G
LSP V Cooperatieve U.A.
|
4.9%
|
$118,457,225
3,424,609 shares
|
$0 | 30 Jun 2026 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
3.8%
|
$51,436,214
2,047,620 shares
|
$0 | 30 Jun 2025 |
| Bain Capital Life Sciences Fund, L.P. |
13D/G
|
2.5%
|
$41,020,425
1,640,817 shares
|
-$5,670,300 | 31 Dec 2025 |
| Berndt Modig |
3/4/5
Chief Executive Officer, Director
|
2.9%
|
$63,754,926
2,030,625 shares
|
-$943,853 | 14 Aug 2026 |
| Anne Lesage |
3/4/5
Chief Early Development
|
0.86%
|
$18,282,680
607,526 shares
|
-$4,758,708 | 29 Jun 2026 |
| Johannes Gerardus Christiaan Petrus Schikan |
3/4/5
Director
|
0.45%
|
$11,186,096
315,167 shares
|
-$2,625,672 | 29 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$12,618,796.
Buys
$0
Insiders: 0
Sells
$12,618,796
Insiders: 11
Net
-$12,618,796
Shares: -394,687
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 394,687
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 197,314 | $0 | $6,729,379 | -$6,729,379 |
| 3-6 | 0 | 197,373 | $0 | $5,889,418 | -$5,889,418 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to Pharvaris N.V.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Largest Forms 3/4/5 holder
Berndt Modig
Net 12M change
-$12,618,796
Latest report
14 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Berndt Modig | Chief Executive Officer, Director | $63,754,926 | -$943,853 | -1.5% | Mixed | 14 Aug 2026 |
| Anne Lesage | Chief Early Development | $18,282,680 | -$4,758,708 | -21% | Mixed | 29 Jun 2026 |
| Johannes Gerardus Christiaan Petrus Schikan | Director | $11,186,096 | -$2,625,672 | -19% | Filing P/S | 29 Jun 2026 |
| David W. Nassif | Cfo / Clo | $3,646,004 | -$303,076 | -7.7% | Filing P/S | 21 May 2026 |
| Annick Deschoolmeester | Chief Human Resources Officer | $2,313,825 | Mixed | 18 Mar 2026 | ||
| Peng Lu | President | $2,253,889 | -$2,235,715 | -50% | Median | 11 Aug 2026 |
| David P. Meeker | Director | $1,629,175 | Mixed | 18 Mar 2026 | ||
| Anna Nijdam | Principal Accounting Officer | $1,428,546 | -$307,481 | -18% | Filing P/S | 04 Jun 2026 |
| Wim Souverijns | Chief Commercial Officer | $1,349,554 | -$299,163 | -18% | Filing P/S | 15 May 2026 |
| Stefan Andreas Abele | Chief Technical Ops Officer | $1,049,481 | -$260,864 | -20% | Filing P/S | 15 May 2026 |
| Elisabeth Bjork | Director | $444,644 | -$293,166 | -40% | Filing P/S | 20 May 2026 |
| Robert Glassman | Director | $313,075 | -$298,245 | -49% | Filing P/S | 15 May 2026 |
| Viviane Monges | Director | $166,617 | -$292,853 | -64% | Filing P/S | 21 May 2026 |
Recent insider transactions for Pharvaris N.V.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Berndt Modig | PHVS | Common Stock | Sale | -1.72% | $79,686 | $34.77 | -2,292 | 130,625 | 14 Aug 2026 | Direct |
| Peng Lu | PHVS | Common Stock | Tax liability | -0.18% | -117 | 65,179 | 12 Aug 2026 | Direct | ||
| Peng Lu | PHVS | Common Stock | Tax liability | -0.17% | -109 | 65,296 | 11 Aug 2026 | Direct | ||
| Berndt Modig | PHVS | Common Stock | Sale | -1.7% | $80,154 | $34.97 | -2,292 | 132,917 | 13 Jul 2026 | Direct |
| Peng Lu | PHVS | Common Stock | Tax liability | -0.18% | -117 | 65,405 | 12 Jul 2026 | Direct | ||
| Peng Lu | PHVS | Common Stock | Tax liability | -0.17% | -109 | 65,522 | 11 Jul 2026 | Direct | ||
| Johannes Gerardus Christiaan Petrus Schikan | PHVS | Common Stock | Sale | -8.88% | $1,090,049 | $35.49 | -30,712 | 315,167 | 30 Jun 2026 | Direct |
| Anne Lesage | PHVS | Common Stock | Sale | -24.6% | $1,089,637 | $35.49 | -30,703 | 93,969 | 30 Jun 2026 | By GrayMatters Consulting BVBA |
| Anne Lesage | PHVS | Common Stock | Sale | -32.2% | $988,890 | $35.48 | -27,872 | 58,750 | 30 Jun 2026 | Direct |
| Anne Lesage | PHVS | Common Stock | Options Exercise | 47.4% | 27,872 | 86,622 | 30 Jun 2026 | Direct | ||
| Anne Lesage | PHVS | Stock Option (Right to Buy) | Options Exercise | -100% | -27,872 | 0 | 30 Jun 2026 | Direct | ||
| Johannes Gerardus Christiaan Petrus Schikan | PHVS | Common Stock | Sale | -1.95% | $241,447 | $35.05 | -6,888 | 345,879 | 29 Jun 2026 | Direct |
| Anne Lesage | PHVS | Common Stock | Sale | -5.31% | $245,232 | $35.05 | -6,997 | 124,672 | 29 Jun 2026 | By GrayMatters Consulting BVBA |
| Anne Lesage | PHVS | Common Stock | Sale | -15.8% | $371,693 | $35.07 | -10,600 | 56,450 | 29 Jun 2026 | Direct |
| Anne Lesage | PHVS | Common Stock | Options Exercise | 18.8% | 10,600 | 67,050 | 29 Jun 2026 | Direct | ||
| Anne Lesage | PHVS | Stock Option (Right to Buy) | Options Exercise | -76.6% | -9,700 | 2,972 | 29 Jun 2026 | Direct | ||
| Johannes Gerardus Christiaan Petrus Schikan | PHVS | Common Stock | Sale | -0.68% | $84,250 | $35.10 | -2,400 | 352,767 | 29 Jun 2026 | Direct |
| Peng Lu | PHVS | Common Stock | Sale | -18.3% | $499,847 | $34.00 | -14,700 | 65,631 | 26 Jun 2026 | Direct |
| Peng Lu | PHVS | Common Stock | Options Exercise | 22.4% | 14,700 | 80,331 | 26 Jun 2026 | Direct | ||
| Peng Lu | PHVS | Stock Option (Right to Buy) | Options Exercise | -7.74% | -14,700 | 175,308 | 26 Jun 2026 | Direct | ||
| Anne Lesage | PHVS | Common Stock | Sale | -1.72% | $80,786 | $35.12 | -2,300 | 131,669 | 25 Jun 2026 | By GrayMatters Consulting BVBA |
| Anne Lesage | PHVS | Common Stock | Sale | -3.91% | $80,775 | $35.12 | -2,300 | 56,450 | 25 Jun 2026 | Direct |
| Anne Lesage | PHVS | Common Stock | Options Exercise | 4.07% | 2,300 | 58,750 | 25 Jun 2026 | Direct | ||
| Anne Lesage | PHVS | Stock Option (Right to Buy) | Options Exercise | -24.5% | -2,300 | 7,072 | 25 Jun 2026 | Direct | ||
| Peng Lu | PHVS | Common Stock | Sale | -18.6% | $518,985 | $34.60 | -15,000 | 65,631 | 25 Jun 2026 | Direct |
| Peng Lu | PHVS | Common Stock | Options Exercise | 22.9% | 15,000 | 80,631 | 25 Jun 2026 | Direct | ||
| Peng Lu | PHVS | Stock Option (Right to Buy) | Options Exercise | -7.32% | -15,000 | 190,008 | 25 Jun 2026 | Direct | ||
| Peng Lu | PHVS | Common Stock | Sale | -0.46% | $10,200 | $34.00 | -300 | 65,631 | 18 Jun 2026 | Direct |
| Peng Lu | PHVS | Common Stock | Options Exercise | 0.46% | 300 | 65,931 | 18 Jun 2026 | Direct | ||
| Peng Lu | PHVS | Stock Option (Right to Buy) | Options Exercise | -0.15% | -300 | 205,008 | 18 Jun 2026 | Direct | ||
| Berndt Modig | PHVS | Common Stock | Sale | -1.67% | $71,173 | $31.07 | -2,291 | 135,209 | 15 Jun 2026 | Direct |
| Peng Lu | PHVS | Common Stock | Tax liability | -0.18% | -117 | 65,631 | 12 Jun 2026 | Direct | ||
| Peng Lu | PHVS | Common Stock | Tax liability | -0.17% | -109 | 65,748 | 11 Jun 2026 | Direct | ||
| Anna Nijdam | PHVS | Common Stock | Sale | -5.46% | $82,425 | $30.87 | -2,670 | 46,275 | 04 Jun 2026 | Direct |
| Anna Nijdam | PHVS | Common Stock | Sale | -10.1% | $169,084 | $30.74 | -5,501 | 48,945 | 22 May 2026 | Direct |
| Anna Nijdam | PHVS | Common Stock | Options Exercise | 11.2% | 5,501 | 54,446 | 22 May 2026 | Direct | ||
| Anna Nijdam | PHVS | Stock Option (Right to Buy) | Options Exercise | -19.5% | -5,501 | 22,670 | 22 May 2026 | Direct | ||
| Viviane Monges | PHVS | Common Stock | Sale | -63.7% | $292,853 | $30.29 | -9,667 | 5,500 | 21 May 2026 | Direct |
| Anna Nijdam | PHVS | Common Stock | Sale | -3.6% | $55,971 | $30.60 | -1,829 | 48,945 | 21 May 2026 | Direct |
| Anna Nijdam | PHVS | Common Stock | Options Exercise | 3.74% | 1,829 | 50,774 | 21 May 2026 | Direct | ||
| Anna Nijdam | PHVS | Stock Option (Right to Buy) | Options Exercise | -6.1% | -1,829 | 28,171 | 21 May 2026 | Direct | ||
| David W. Nassif | PHVS | Common Stock | Sale | -7.67% | $303,076 | $30.31 | -10,000 | 120,300 | 21 May 2026 | Direct |
| Elisabeth Bjork | PHVS | Common Stock | Sale | -39.7% | $293,166 | $29.32 | -10,000 | 15,167 | 20 May 2026 | Direct |
| Elisabeth Bjork | PHVS | Common Stock | Options Exercise | 65.9% | 10,000 | 25,167 | 20 May 2026 | Direct | ||
| Elisabeth Bjork | PHVS | Stock Option (Right to Buy) | Options Exercise | -47.6% | -10,000 | 11,000 | 20 May 2026 | Direct | ||
| Robert Glassman | PHVS | Common Stock | Sale | -48.8% | $298,245 | $29.82 | -10,000 | 10,500 | 15 May 2026 | Direct |
| Robert Glassman | PHVS | Common Stock | Options Exercise | 35.2% | 5,333 | 20,500 | 15 May 2026 | Direct | ||
| Robert Glassman | PHVS | Stock Option (Right to Buy) | Options Exercise | -38.1% | -5,333 | 8,667 | 15 May 2026 | Direct | ||
| Stefan Andreas Abele | PHVS | Common Stock | Sale | -19.9% | $260,864 | $29.82 | -8,748 | 35,194 | 15 May 2026 | Direct |
| Wim Souverijns | PHVS | Common Stock | Sale | -18.2% | $299,163 | $29.92 | -10,000 | 45,111 | 15 May 2026 | Direct |
* marks a reported price that did not pass the local price check.